Ovotransferrin (OTF) is a well-known protein of the transferrin family with
strong iron chelating activity, resulting in its antimicrobial activity.
Furthermore, OTF is known to have antioxidant, anticancer, and antihypertensive
activities. However, there have been few studies about the immune-enhancing
activity of OTF. In current study, we investigated the immune-enhancing activity
of OTF using the murine macrophage cells in vitro. The effect
of OTF on production of pro-inflammatory mediators and cytokines were determined
using Griess assay and quantitative real-time PCR. Using Neutral Red uptake
assay, we confirmed the effect of OTF on phagocytic activity of macrophages.
Ovotransferrin significantly increased the production of nitric oxide (NO) and
secretion of inducible nitric oxide synthase (iNOS) mRNA with no cytotoxic
activity. Ovotransferrin (2 mg/mL) stimulated NO production up to
31.9±3.5 μM. Ovotransferrin significantly increased the mRNA
expression levels of pro-inflammatory cytokines which are tumor necrosis
factor-α (TNF-α), Interleukin-1β (IL-1β), and IL-6:
OTF (2 mg/mL) treatment increased the secretion of mRNA for TNF-α,
IL-1β, and IL-6 by 22.20-, 37.91-, and 6.17-fold of the negative control,
respectively. The phagocytic activity of macrophages was also increased by OTF
treatment significantly compared with negative control. Also, OTF treatment
increased phosphorylation level of MAPK signaling pathways. These results
indicated that OTF has immune-enhancing activity by activating RAW 264.7
macrophages via MAPK pathways.